Considering that Ru-PIP treatment led to stalled DNA replication fork progression and PARP is activated upon DNA-strand break to prevent fork collapse, we hypothesized that this combination would result in sustained DNA damage leading to enhanced cytotoxic effect on cancer cells. Here, PARP1 is linked to cancer.